Company Overview and News

Havells clocks Q4 profit rises to Rs226 crore

2018-05-11 livemint
New Delhi: Havells India on Friday reported a standalone net profit of Rs225.76 crore and total income of Rs2,560.64 crore for the quarter ended 31 March, 2018.

After acquisition by Havells India, Lloyd eyes ₹3,000-crore turnover

2017-10-09 thehindubusinessline
After acquiring the Lloyd brand of consumer durables early this year, Havells India is targeting sales of ₹3,000 crore from the white goods category.

Company news

2017-05-24 thehindubusinessline
India Cements has fixed June 9 as the record date to determine the shareholders of Trinetra Cement and Trishul Concrete Products who are eligible to receive equity shares of the company under a scheme of arrangement. The company has received approval from the National Company Law Tribunal, Division Bench, Chennai. Trinetra Cement (listed) and Trishul Concrete (unlisted) are subsidiaries of India Cements, which are to be merged with itself.

Reliance Retail-Heritage Foods deal, 2 others get CCI nod

2017-04-10 business-standard
The Competition Commission has approved the proposed acquisition of Reliance Retail's dairy business by Heritage Foods apart from two other deals. Havells' purchase of Lloyd's consumer durables and the deal involving DHFL Pramerica Life Insurance Company have been cleared, the watchdog said.

Fedders Lloyd Corporation intimates of listing of 32 lakh shares on exchanges

2017-03-18 indiainfoline
Disclaimer: The contents herein is specifically prepared by ‘Dalal Street Investment Journal’, and is for your information & personal consumption only. India Infoline Limited or Dalal Street Investment Journal do not guarantee the accuracy, correctness, completeness or reliability of information contained herein and shall not be held responsible.

Lloyd seeks shareholders' nod to sell consumer biz to Havells

2017-02-22 moneycontrol
Ensure that your correct email id and mobile has been registered with moneycontrol. If not, please update your profile and secure the account now. Updating your email id and mobile number offers following benefits:

Analyst take: Havells-Lloyd deal 'win-win' for both

2017-02-20 moneycontrol
Ensure that your correct email id and mobile has been registered with moneycontrol. If not, please update your profile and secure the account now. Updating your email id and mobile number offers following benefits:

Havells to buy Lloyds consumer durables biz for Rs 1600 cr

2017-02-19 moneycontrol
Ensure that your correct email id and mobile has been registered with moneycontrol. If not, please update your profile and secure the account now. Updating your email id and mobile number offers following benefits:

Havells to buy Lloyd’s consumer durables biz

2017-02-19 thehindubusinessline
The deal, with an enterprise value of ₹1,600 crore, will help the firm enter white goods segment

Fedders Lloyd Corporation allots 11.40 lakh equity shares

2017-01-13 indiainfoline is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

Fedders Lloyd Corporation allots equity shares

2016-12-30 indiainfoline
Subsequent to the above allotment, the paid up share capital of the Company has increase to Rs 32.82 crore comprising of 3,28,29,700 equity shares of Rs 10 each.

New CEO for WABAG India cluster

2016-12-09 thehindubusinessline
VA Tech Wabag has appointed Pankaj Sachdeva as Chief Executive Officer (CEO) for WABAG India Cluster from November 28, 2016. He will be based in Chennai office and handle the management and supervision of the WABAG India Cluster of the integrated water and waste water management and recycling multinational, said a statement from the company.

Wabag India cluster appoints Pankaj Sachdeva as new CEO

2016-12-03 business-standard
Pankaj Sachdeva has been appointed as the new Chief Executive Officer (CEO) of Wabag India Cluster. Prior to joining Wabag, Sachdeva was Executive President with Fedders Lloyd Corporation. Previous to that, he was Joint Group President and Group Director at Skipper SEIL International, JLT, Dubai.

Fedders Lloyd Corp gains 4% on 2 orders worth Rs 390 cr

2016-11-15 moneycontrol
The company has bagged orders worth Rs 296 crore from Chhattisgarh State Power Distribution Company under the Deen Dayal Upadhyay Gramin Jyoti Yojna (DDUGJY).

Stocks in news: Tata Motors, Axis, BoB, Hindalco, Ujjivan, Dish

2016-11-15 moneycontrol
Tata Motors | Tata Steel | Axis Bank | Bank of Baroda | Hindalco Industries | Patel Engineering | LT Foods | SREI Infra | Ujjivan | Dish TV | Future Retail | Kotak Mahindra Bank | Fedders Lloyd | HSIL | Indian Hume Pipe | Fiem Industries and Suzlon are stocks, which are in the news today.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

21h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

22h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...